Long-term analysis of intravitreal brolucizumab in recalcitrant cases of chronic central serous retinopathy complicated by neovascularization (pachychoroid neovasculopathy).

Indian J Ophthalmol · 2026 · PMC13271552 · PMID 42200740

Europe PMC DOI

hedged sentence

0.0010

closest p · 0.0× alpha

0.0010

boldest claim

The sentences

highly significantP < 0.001actually significant

Additionally, the mean CST changed from 328.03 ± 222.06 μm at baseline to 172.43 ± 78.76 μm, representing a highly significant anatomical improvement, with a large effect size ( P < 0.001, r = 0.827).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.